Antibacterial resistance associated with long-term care facilities

Reviews and Research in Medical Microbiology

Volumn 19, Issue 2, 2008, Pages 47-55

  Urban, Carl ^a,b   Wehbeh, Wehbeh ^a,b   Rahal, James J ^a,b  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antibacterial resistance; Detection of resistance; Infection control; Long term care facilities

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; OFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; TIGECYCLINE; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIUM DETECTION; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; LABORATORY; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 67650035161     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e32831a4125     Document Type: Review

References (72)

1. Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 1996; 9:1-17.
2. Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EG, Smith PW. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 2000; 21:537-545.
3. Bonomo RA. Multiple antibiotic-resistant bacteria in longterm-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis 2000; 3:1414-1422.
4. Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant Enterococci. Clin Infect Dis 2002; 34:441-446.
5. Appelbaum PC. Microbiology of antibiotic resistance in Staphylococcus aureus. Clin Infect Dis 2007; 45:S165-S170.
6. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Med 2006; 119:S11-S19.
7. Appelbaum PC. Reduced glycopeptide susceptibility in methicillin-resistant Staphyococcus aureus (MRSA). Int J Antimicrob Agents 2007; 30:398-108.
8. Urban C, Rahman N, Zhao X, Mariano N, Segal-Maurer S, Drlica K, et al. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J Infect Dis 2000; 184:794-798.
9. Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 2002; 34:16131620.
10. Gaynes R, Rimland D, Killum E, Lowery HK, Johnson TM, Killgore G, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004; 38:640-645.
11. Makris AT, Gelone S. Clostridium difficile in the long-term care setting. J Am Med Dir Assoc 2007; 8:290-299.
12. Wehbeh W, Rojas-Diaz R, Li X, Mariano N, Grenner L, SegalMaurer S, et al. Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob Agents Chemother 2005; 49:2495-2497.
13. Lautenbach E, Polk RE. Resistant gram-negative bacilli: a neglected healthcare crisis? Am J Health-Syst Pharm 2007; 64:S3-S21.
14. Paterson DL, Bonomo RA. Extended-spectrum ß-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-686.
15. Urban C, Rahal J. Mechanisms and detection of carbapenem resistance in Pseudomonas areuginosa, Klebsiella pneumoniae and Acinetobacter baumannii. Rev Med Microbiol 2004; 15:63-72.
16. Labombardi VJ. The emergence of the KPC carbapenemases: clinical and laboratory issues. Rev Med Micobiol 2007; 18:29-34.
17. NazirJ, Urban C, Mariano N, Burns J, Tommasulo B, Rosenberg C, et al. Quinolone-resistant Haemophilus influenzae in a longterm care facility: clinical and molecular epidemiology. Clin Infect Dis 2004; 38:1564-1569.
18. Jacoby GA. Mechanisms of quinolone resistance. Clin Infect Dis 2005; 41:S120-S126.
19. Richards CL. Infection control in long-term care facilities. J Am Med Dir Assoc 2007; 8:S18-S25.
20. Kreman T, Hu J, Pottinger J, Herwaldt LA. Survey of long-term care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococci. Infect Control Hosp Epidemiol 2005; 26:811-815.
21. Crnich CJ, Safdar N, Robinson J, Zimmerman D. Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004. Infect Control Hosp Epidemiol 2007; 28:1006-1008.
22. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006; 42:S25-S34.
23. Mannheimer SB, Riley LW, Roberts RB. Association of penicillin-resistant pneumococci with residence in a pediatric chronic care facility. J Infect Dis 1996; 174:513-519.
24. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder P, et al. An outbreak of multidrug-resistant pneumococcal
25. Kneumoniae and bacteremia among unvaccinated nursing ome residents. N Engl J Med 1998; 338:1861-1868.
26. Fry AM, Udeagu CCN, Soriano-Gabarro M, Fridkin S, Musinski D, LaClaire L, et al. Persistance of fluoroquinolone-resistant, multidrug- resistant Streptococcus pneumoniae in a long-termcare facility: efforts to reduce intrafacility transmission. Infect Control Hosp Epidemiol 2005; 26:239-247.
27. Bonomo RA. Resistant pathogens in respiratory tract infections in older people. J Am Ceriatr Soc 2002; 50:S236-S241.
28. Kuppronis BA, Richards CL, Whitney CG. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 2003; 51:1520-1525.
29. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A, for the Toronto Invasive Bacterial Disease Network. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40:1288-1297.
30. Lim S, Bast D, McGeer A, de Azavedo J, Low D. Antimicrobial breakpoints and first strep mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg Infect Dis 2003; 9:833-837.
31. Moellering RC Jr. Current treatment options for communityacquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46:1032-1037.
32. Nicholas-Chanoine M-H, Jarlier V. Extended-spectrum ß-lactamases in long-term care facilities. Clin Microbiol Infect 2008; 14:111-116.
33. Rice LB, Wiley SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moelleri ng RC Jr, et al. Outbreak of ceftazidime resistance caused by extended-spectrum ß-lactamases at a Massachusetts chronic-care facility. Antimicrb Agents Chemother 1990; 34:2193-2199.
34. Bradford PA, Urban C, Jaiswal A, Mariano N, Rasmussen BA, Projan SJ, et al. SHV-7, a novel cefotaxime-hydrolyzing ßlactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother 1995; 39:899-905.
35. Meyer KS, Urban C, Eagan J, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Ann Intern Med 1993; 119:353358.
36. Urban C, Meyer KS, Mariano N, Rahal JJ, Flamm R, Rasmussen BA, et al. Identification of TEM-26 ß-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 1994; 38:392395.
37. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:51 7-523.
38. Oteo J, Navarro C, Cercenado E, Delgado-lribarren A, Wilhelmi I, Orden B, et al. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 2006; 44:23592366.
39. Kassis-Chikhani N, Vimont S, Asselat K, Trivalle C, Minassian B, Sengelin C, et al. CTX-M beta-lactamase-producing Escherichia coli in long-term care facilities, France, Emerg Infect Dis 2004; 10:1697-1698.
40. Sandoval C, Walter SD, McGeer A, Simor AE, Bradley SF, Moss LM, et al. Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins, Emerg Infect Dis 2004; 10:1050-1055.
41. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24:17-22.
42. Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, et al. Emergence of carbapenem-resistant Klebsiella spp. possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 B-lactamases in New York City. Clin Infect Dis 2004; 39:55-60.
43. Chiang T, Mariano N, Urban C, Colon-Urban R, Grenner L, Eng RHK, et al. Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb Drug Resist 2007; 13:235-239.
44. Southwick KL, Kornblum J, Scott C, Budnah R, Fu J, Chen M, et al. Widespread occurrence of a multiply resistant clone of Klebsiella pneumoniae in New York City Hospitals. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 2005. Abstract # K-1502.
45. Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase ß-lactamases associated with long-term care facilities. Clin Infect Dis 2008; 46:e127-e130.
46. Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001; 22:316-321.
47. Urban C, Mariano N, Bradford PA, Tuchman M, Segal-Maurer S, Wehbeh W, et al. Identification of CTX-M ß-lactamases in Escherichia coli (Ec) from both hospitalized patients and residents of long-term care facilities (LTCFs). 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting Infectious Diseases Society of America 2008; 2652.
48. Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis 2007; 45:11791181. 48. Maslow JN, Lee B, Lautenbach E. Fluoroquinolone-resistant Escherichia coli carriage in long-term Care Facility, Emerg Infect Dis 2005; 11:889-894.
49. Kay RS, Vandevelde AG, Fiorella PD, Crouse R, Blackmore C, Sanderson R, et al. Outbreak of healthcare-associated infection and colonization with multidrug-resistant Salmonella entérica serovar senftenberg in Florida. Infect Control Hosp Epidemiol 2007; 28:805-811.
50. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2003; 36:S11-S23.
51. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115:585-590.
52. Medeiros AA. Relapsing infection due to Enterobacter species: lessons learned from heterogeneity [editorial response]. Clin Infect Dis 1997; 25:341-342.
53. Thiolas A, Bollet C, La Scola B, Raoult D, Pages JM. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and Colistin in a patient. Antimicrob Agents Chemother 2005; 49:1354-1358.
54. Rahal JJ. Novel antibiotic combinations against infections almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43:S95-S99.
55. Alba J, Ishii Y, Thomson K, Moland ES, Yamaguchi K. Kinetics of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 2005; 49: 4760-4762.
56. Fritsche TR, Sader HS, Jones RN. Antimicrobial activity of ceftobiprole, a novel antimethicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY antimicrobial surveillance program (2005-2006). Diagn Microbiol Infect Dis 2008; 61: 86-95.
57. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233-1237.
58. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the balloon at multiple sites. Clin Infect Dis 2002; 34:499-503.
59. Livermore DM, Pearson A. Antibiotic resistance: location, location, location. Clin Microbiol Infect 2007; 13:7-16.
60. Tenover FC, Kaisi RK, Williams PP, Carey RB, Stocker S, Lonsway D, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006; 12:1209-1213.
61. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005; 49:3018-3020.
62. Tam VH, Gamez EA, Weston JS, Gerard LN, LaRocco MT, Caeiro JP, et al. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Clin Infect Dis 2008; 46:862-867.
63. Frei CR, Wiederhold NP, Burgess DS. Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation. J Antimicrob Chemother 2008; 61:621-628.
64. Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev2007; 20:391-408.
65. Drinka PJ, Crnich CJ. An approach to endemic multidrugresistant bacteria in nursing homes. J Am Med Dir Assoc 2005; 6:132-136.
66. Richards CL. Preventing antimicrobial-resistant bacterial infections among older adults in long-term care facilities. J Am Med Dir Assoc 2005; 6:144-151.
67. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003; 36:1268-1274.
68. Saeed S, Fakih MG, Riederer K, Shah AR, Khatib R. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence based polymerase chain reaction. Infect Control Hosp Epidemiol 2006; 27:981-983.
69. Stephens C, Francis SJ, Abell V, Di Persio JR, Wells P. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control 2007; 35:212-215.
70. Carter RJ, Sorenson G, Heffernan R, Kiehlbauch JA, Kornblum JS, Leggiadro RJ, et al. Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: emergence and ongoing transmission of a fluoroquinolone-resistant strain. Infect Control Hosp Epidemiol 2005; 26:248-255.
71. Urban C, Mariano N, Rahman N, Queenan AM, Montenegro D, Bush K, et al. Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins. Microb Drug Resist 2000; 6:297-303.
72. Seppala H, Klaukka T, Vuopa-Varila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in consumption of macrolide antibiotic on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 33:441-146.